Free access

Short Communication

14 December 2021

An economic evaluation of reducing colorectal cancer surveillance intensity

Authors: Benjamin Allaire https://orcid.org/0000-0002-7033-2129, Robbie Skinner https://orcid.org/0000-0002-0195-2121 [email protected], Grant King, Amanda Honeycutt https://orcid.org/0000-0003-0166-1399, and Dominick EspositoAuthor Info & Affiliations

Publication: Journal of Comparative Effectiveness Research

Volume 11, Number 2

https://doi.org/10.2217/cer-2021-0065

PDF OtherFormats

Abstract

Aim: Analyze the impact of national implementation of ‘low intensity’ post-treatment colorectal cancer surveillance compared with current practices. Materials & methods: Create a population-level Markov model to estimate impacts of expansion of low versus high intensity surveillance post-treatment on healthcare utilization, costs and caregiver time loss. Results: Shifting to low intensity colorectal cancer surveillance would reduce patient burden by 301,830 h per patient annually over 5 years. Cost reductions over 5 years were US$43.5 million for Medicare and US$4.2 million for Medicaid. Total societal cost savings equaled US$104.2 million. Conclusion: National implementation of low intensity post-treatment colorectal cancer surveillance has the potential to significantly reduce burden and costs on patients and their caregivers with no added risks to health.

Supplementary Material

File (supplementary materials.docx)

Download
20.80 KB

References

1.

SEER (Surveillance Epidemiology and End Results Program). Cancer stat facts: colorectal cancer. https://seer.cancer.gov/statfacts/html/colorect.html (2018).

2.

Snyder RA, Hu C-Y, Cuddy A et al. Association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer. JAMA 319(20), 2104–2115 (2018).

3.

Myer PA, Mannalithara A, Singh G, Ladabaum U. Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy. Gastroenterology 143(5), 1227–1236 (2012).

4.

U.S. Census Bureau. Quickfacts: United States. https://www.census.gov/quickfacts/fact/table/US#

5.

SEER. Age Distribution of Incidence Cases by Site, 2011-2015: All Races, Both Sexes. https://seer.cancer.gov/csr/1975_2015/results_single/sect_01_table.11_2pgs.pdf

6.

Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. Chapter 4. Oxford University Press, NY, USA (2006).

7.

Dusetzina SB, Basch E, Keating NL. For uninsured cancer patients, outpatient charges can be costly, putting treatments out of reach. Health Affairs 34(4), 584–591 (2015).

8.

CMS (Centers for Medicare & Medicaid Services). Clinical laboratory fee schedule. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Clinical-Laboratory-Fee-Schedule-Files-Items/18CLAB.html?DLPage=1&DLEntries=10&DLSort=2&DLSortDir=descending

9.

CMS (Centers for Medicare & Medicaid Services). Physician fee schedule. https://www.cms.gov/apps/physician-fee-schedule/search/search-criteria.aspx

10.

Yabroff KR, Davis WW, Lamont EB et al. Patient time costs associated with cancer care. J. Natl Cancer Inst. 99(1), 14–23 (2007).

11.

BLS DOL (Bureau of Labor Statistics, U.S. Department of Labor). Earnings, median usual weekly earnings, employed full time, 2018, by quarter. Labor force statistics from the Current Population Survey. Series ID LEU0252881500. https://www.bls.gov/cps/

12.

BLS DOL (Bureau of Labor Statistics, U.S. Department of Labor). Employer costs for employee compensation for December 2018 [News release]. https://www.bls.gov/regions/southwest/news-release/employercostsforemployeecompensation_regions.htm

13.

Wolff JL, Roter DL. Family presence in routine medical visits: a meta-analytical review. Social Sci. Med. 72(6), 823–831 (2011).

14.

BLS DOL (Bureau of Labor Statistics, U.S. Department of Labor). Earnings, median usual weekly earnings, employed full time, 2018. Labor force statistics from the Current Population Survey. Series ID LEU0254543600, LEU0258117500. https://www.bls.gov/cps/

15.

Yabroff KR, Mariotto AB, Feuer E, Brown ML. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. Health Econ. 17, 947–959 (2008).

16.

NCNN (National Comprehensive Cancer Network). NCCN guidelines for patients: colon cancer. https://www.nccn.org/patients/guidelines/colon/files/assets/common/downloads/files/colon.pdf

17.

Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C. Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review. World J. Gastrointest. Oncol. 6(5), 104–111 (2014).

|